Well the monopoly exists by virtue of the patent and/or the regulatory exclusivity in the market.
Question then is how would that activity impede the entry or expansion of new competitors in the market?
Well it cant if we take the view that the market is FDA regulated prescription drug market only. Competitors aren't allowed in , in the first place during the exclusivity/patent protected period.
However, if the market is viewed as both FDA approved & OTC then I would agree. That though would be quite a statement as surely these are two different market places? Certainly the laws and regulations governing both arenas are different as are the barriers to entry, pricing, customer group etc,etc.
Vertical integration is not unheard of in these circumstances and is in my view a good way to tie up with certainty the quality and quantity of product Amarin needs.
Market Data 
Markets 
AI
